Skip to content
Screener

Foghorn Therapeutics FHTX Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$7.6MMiss by $616.0K
EPS-$0.28Beat by $0.03
Revenue estimate$8.2M
EPS estimate-$0.31

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$7.1M
EPS estimate-$0.22

FAQ

When did Foghorn Therapeutics report Q2 2025 earnings?
Foghorn Therapeutics (FHTX) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Foghorn Therapeutics's Q2 2025 revenue and EPS?
Foghorn Therapeutics reported revenue of $7.6M and eps of $-0.28 for Q2 2025.
Did Foghorn Therapeutics beat estimates in Q2 2025?
Revenue missed the consensus estimate of $8.2M by $616.0K. EPS beat the consensus estimate of $-0.31 by $0.03.
How did Foghorn Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.7% from $6.9M a year earlier and eps grew 37.8% from $-0.45.
Where can I find Foghorn Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-037603) and the 10-Q periodic report (0001628280-25-037606) directly on SEC EDGAR. The filing index links above go to sec.gov.